TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35964661

Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel implant (0 to 2 hours postdelivery)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel implant (24 to 48 hours postdelivery)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel implant
Number of subjects: 95

Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel implant
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study: 33544985

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser activation of 40% H2O2
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 810-nm diode laser activation of 40% H2O2
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: LED activation of 40% H2O2
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Conventional (chemical) treatment of 40% H2O2
Number of subjects: 80
Study: 34387114

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine (low doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisone (40 mg or equivalent)
Number of subjects: 0
Study: 33772364

Group type: EXPERIMENTAL
Intervention: Virtual integrative oncology treatments (e.g., live-streamed or on-demand programs, one-on-one virtual appointments for acupressure and self-care massage)
Number of subjects: 16366

Group type: EXPERIMENTAL
Intervention: Virtual consent and intervention delivery for integrative oncology studies (Yoga and Music Therapy)
Number of subjects: 16366
Study: 32164613

Group type: EXPERIMENTAL
Intervention: Prophylactic clip application (group A)
Number of subjects: 116

Group type: COMPARATOR
Intervention: No prophylactic clip application (group B)
Number of subjects: 116
Study: 34988702

Group type: EXPERIMENTAL
Intervention: EVOH-Onyx® (group 1, n=3)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Microspheres 500 µ (group 2, n=3)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2-mm micro-coils (group 3, n=3)
Number of subjects: 9
Study: 35536640

Group type: EXPERIMENTAL
Intervention: mHealth program (self-regulation component, narrative, and chatbot)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: self-regulation and narrative components
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: chatbot use
Number of subjects: 186

Group type: COMPARATOR
Intervention: nonacademic educational track
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: reasons for nonusage attrition
Number of subjects: 186
Study: 33081828

Group type: EXPERIMENTAL
Intervention: Tocilizumab (1-h intravenous infusion)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 80
Study: 35364216

Group type: EXPERIMENTAL
Intervention: CTP-543 4 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CTP-543 8 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CTP-543 12 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35150488

Group type: EXPERIMENTAL
Intervention: Psychiatric patients' belief in demonic possession as associated with psychiatric illness
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Desire for a priest in the therapeutic team among psychiatric patients
Number of subjects: 408

Group type: COMPARATOR
Intervention: Attendance of religious services among psychiatrists
Number of subjects: 408
Study: 35010938

Group type: EXPERIMENTAL
Intervention: Intensive medical nutrition therapy (MNT) plus metformin (850 mg twice/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intensive medical nutrition therapy (MNT) without metformin
Number of subjects: 90
Study: 35322793

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 54

Group type: COMPARATOR
Intervention: Combination of empagliflozin and benzbromarone
Number of subjects: 54
Study: 33186771

Group type: EXPERIMENTAL
Intervention: Uterine Toxin Botulinic injections (BTX) under hysteroscopy (200 IU of Incobotulinum-toxin A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Uterine Toxin Botulinic injections (BTX) under hysteroscopy
Number of subjects: 30
Study: 35019175

Group type: EXPERIMENTAL
Intervention: Dronedarone 400 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32517728

Group type: EXPERIMENTAL
Intervention: Subclinical pulmonary emphysema
Number of subjects: 687

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 687

Group type: COMPARATOR
Intervention: Family history of lung disease
Number of subjects: 687

Group type: COMPARATOR
Intervention: Lower body mass index
Number of subjects: 687

Group type: COMPARATOR
Intervention: Telomere length and Klotho serum concentration
Number of subjects: 687
Study: 34571181

Group type: EXPERIMENTAL
Intervention: HTO+P-PRP
Number of subjects: 80

Group type: COMPARATOR
Intervention: HTO alone
Number of subjects: 80
Study: 32379668

Group type: EXPERIMENTAL
Intervention: Benson relaxation technique (BRT), performed twice daily for 20 min over one month
Number of subjects: 65
Study: 33342624

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35034428

Group type: EXPERIMENTAL
Intervention: Insulin-GLP-1 RA relay group (mean 16.8 ± 11.4 IU/day for 12 weeks, then liraglutide for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLP-1 RA first group (liraglutide 0.9 mg for 24 weeks)
Number of subjects: 0
Study: 32844904

Group type: EXPERIMENTAL
Intervention: Bt cotton expressing Cry1F and Cry1Ac proteins
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isohybrid cotton
Number of subjects: 40
Study: 36002047

Group type: EXPERIMENTAL
Intervention: Transcatheter edge‐to‐edge repair (TEER)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: TEER
Number of subjects: 144
Study: 33766513

Group type: EXPERIMENTAL
Intervention: Tokuyama bond force II™
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal™
Number of subjects: 270

Group type: COMPARATOR
Intervention: Positive control group
Number of subjects: 270
Study: 32740512

Group type: EXPERIMENTAL
Intervention: IV Dexmedetomidine 0.6 microgram/kg 30 minutes preoperatively
Number of subjects: 12
Study: 35820444

Group type: EXPERIMENTAL
Intervention: Accelerated systemic fibrinolytic therapy (FT) with 100 mg t-PA in 2 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full-dose systemic fibrinolysis
Number of subjects: 0
Study: 33526167

Group type: EXPERIMENTAL
Intervention: Chlamydia education and training program for general practice nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training for general practice nurses
Number of subjects: 0
Study: 33136819

Group type: EXPERIMENTAL
Intervention: Peer change agent Type I network intervention with opinion leader workshop and telephonic booster sessions
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Peer change agent Type I network intervention
Number of subjects: 423

Group type: COMPARATOR
Intervention: Time-matched control
Number of subjects: 423
Study: 33327936

Group type: EXPERIMENTAL
Intervention: Early foster care intervention (randomized controlled trial)
Number of subjects: 3471

Group type: EXPERIMENTAL
Intervention: Duration of childhood exposure to institutional care
Number of subjects: 3471

Group type: EXPERIMENTAL
Intervention: Psychosocial deprivation in US families
Number of subjects: 3471

Group type: COMPARATOR
Intervention: Never institutionalized counterparts
Number of subjects: 3471
Study: 36360914

Group type: EXPERIMENTAL
Intervention: Theacrine supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 34328444

Group type: EXPERIMENTAL
Intervention: Data model based on FHIR standard
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Topic modeling analysis
Number of subjects: 1200
Study: 32300129

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation online session
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control
Number of subjects: 326
Study: 35799408

Group type: EXPERIMENTAL
Intervention: Thoracic Spine Manipulation (TSM)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Thoracic Spine Mobility Exercises (TSME)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: TSME
Number of subjects: 26

Group type: COMPARATOR
Intervention: TSM
Number of subjects: 26
Study: 32769832

Group type: EXPERIMENTAL
Intervention: Individualized Education Plan (IEP) services
Number of subjects: 74

Group type: COMPARATOR
Intervention: Informal or no services
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Sex (male)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Severity of TBI (severe)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Domain-specific concerns reported by parents
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Sex (female)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Less severe or less visible deficits
Number of subjects: 74
Study: 32310145

Group type: EXPERIMENTAL
Intervention: VIH‐TAVIE (web-based intervention)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Websites (control group)
Number of subjects: 88
Study: 36389110

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the theory of planned behaviour; one-hour lecture session supported by audio-video materials for PA promotion
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 126
Study: 32223649

Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment of physician's choice
Number of subjects: 0
Study: 35094962

Group type: EXPERIMENTAL
Intervention: Comprehensive nonvalidated questionnaire on smoking in relation to bladder cancer
Number of subjects: 370
Study: 34456270

Group type: EXPERIMENTAL
Intervention: Vaccinated group (HPV vaccination)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Nonvaccinated group (no HPV vaccination)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 331
Study: 34242256

Group type: EXPERIMENTAL
Intervention: Mobile text messages related to cancer risk factors once a day for two months
Number of subjects: 0

Group type: COMPARATOR
Intervention: General health messages daily for two months
Number of subjects: 0
Study: 616517401

Group type: EXPERIMENTAL
Intervention: HESWO
Number of subjects: 12

Group type: COMPARATOR
Intervention: RGO
Number of subjects: 12
Study: 35025824

Group type: EXPERIMENTAL
Intervention: Cognitive behavior oriented psychological intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fractional photothermolysis
Number of subjects: 48
Study: 34114691

Group type: EXPERIMENTAL
Intervention: AUC-targeted therapeutic drug monitoring (TDM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ctrough-targeted TDM
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AUC-targeted TDM
Number of subjects: 40
Study: 33448906

Group type: EXPERIMENTAL
Intervention: 3 oz/d almond
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.5 oz/d almond
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3.5 oz/d snack (control)
Number of subjects: 60
Study: 32406699

Group type: EXPERIMENTAL
Intervention: Queer People of Color Identity Affirmation Scale (QPIAS)
Number of subjects: 703
Study: 34847589

Group type: EXPERIMENTAL
Intervention: Fast-velocity concentric resistance training (10 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33203542

Group type: EXPERIMENTAL
Intervention: SEEK training and implementation
Number of subjects: 924

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 924
Study: 35354647

Group type: EXPERIMENTAL
Intervention: Ambulatory care management
Number of subjects: 236

Group type: COMPARATOR
Intervention: Standard guideline-based management
Number of subjects: 236
Study: 34569167

Group type: EXPERIMENTAL
Intervention: Risedronate (150 mg once monthly)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32719133

Group type: EXPERIMENTAL
Intervention: Experiments involving randomization of policies or treatments
Number of subjects: 1955

Group type: COMPARATOR
Intervention: Approval of policies or treatments
Number of subjects: 1955
Study: 34746964

Group type: EXPERIMENTAL
Intervention: Structured interview
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician assessment
Number of subjects: 0
Study: 32744395

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Insulin glargine U300 (IGlarU300)
Number of subjects: 46
Study: 35124626

Group type: EXPERIMENTAL
Intervention: Motion style acupuncture therapy (MSAT) combined with conventional acupuncture therapy (CAT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional acupuncture therapy (CAT)
Number of subjects: 76
Study: 33548422

Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard gauze
Number of subjects: 242
Study: 32904701

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Allopurinol (in COPD patients with severe airflow limitation)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (in COPD patients with severe airflow limitation)
Number of subjects: 71
Study: 35752582

Group type: EXPERIMENTAL
Intervention: Gefapixant 15 mg BID
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Gefapixant 45 mg BID
Number of subjects: 169
Study: 32118753

Group type: EXPERIMENTAL
Intervention: Shi's Yi-Qi Bu-Shen Tong-Luo decoction (BTD) combined with wrist manipulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 36116385

Group type: EXPERIMENTAL
Intervention: Crossword and word search puzzles used as a teaching technique; applied over four weeks during the semester.
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Qualitative feedback from focus group discussions.
Number of subjects: 96
Study: 32272623

Group type: EXPERIMENTAL
Intervention: Solution-focused group counseling intervention for five weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study: 36049494

Group type: EXPERIMENTAL
Intervention: Amitriptyline supplemented with pregabalin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin supplemented with amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duloxetine supplemented with pregabalin
Number of subjects: 0
Study: 33960181

Group type: EXPERIMENTAL
Intervention: Oral sensorimotor stimulation (20 minutes before conventional therapy)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional physical therapy (90 minutes, five times/week for four months)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Oral sensorimotor stimulation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 71
Study: 32807209

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg orally daily for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35622090

Group type: EXPERIMENTAL
Intervention: Anodal transcutaneous spinal direct current stimulation (tsDCS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study: 32036406

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups (including TENS, placebo, and control)
Number of subjects: 45
Study: 36026988

Group type: EXPERIMENTAL
Intervention: SHEPP intervention
Number of subjects: 982

Group type: COMPARATOR
Intervention: Routine Activity school
Number of subjects: 982
Study: 33888314

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (15 mg/kg, maximum 1 g)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32702212

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 300
Study: 32286247

Group type: EXPERIMENTAL
Intervention: Yoga training for 12 weeks, 1 hour each morning
Number of subjects: 66

Group type: COMPARATOR
Intervention: No yoga training (Control)
Number of subjects: 66
Study: 36018547

Group type: EXPERIMENTAL
Intervention: Camel milk
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33340316

Group type: EXPERIMENTAL
Intervention: Baloxavir (40/80 mg single dose based on weight)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 36412085

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 22368

Group type: COMPARATOR
Intervention: Low-risk group
Number of subjects: 22368
Study: 33612637

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 112

Group type: COMPARATOR
Intervention: Non-exclusive breastfeeding
Number of subjects: 112
Study: 36083194

Group type: EXPERIMENTAL
Intervention: Video-Based Capillary Refill Time (VB-CRT) assessment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Bedside Capillary Refill Time (CRT) assessment
Number of subjects: 99
Study: 33158839

Group type: EXPERIMENTAL
Intervention: Acute Stress of Health Professionals Caring COVID‐19 Scale (EASE)
Number of subjects: 685

Group type: COMPARATOR
Intervention: Territory affected by COVID-19
Number of subjects: 685

Group type: COMPARATOR
Intervention: Evolutionary stage of the COVID-19 outbreak
Number of subjects: 685
Study: 36073362

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris L.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 33446159

Group type: EXPERIMENTAL
Intervention: Velocity-specific exercise (VSE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isometric exercise (IE)
Number of subjects: 30
Study: 32227772

Group type: EXPERIMENTAL
Intervention: Xinglou Chengqi (XLCQ) decoction
Number of subjects: 317

Group type: COMPARATOR
Intervention: Clysis therapy using glycerin enemas or lactulose oral solution (Control)
Number of subjects: 317
Study: 35074417

Group type: EXPERIMENTAL
Intervention: Leaflet resection
Number of subjects: 104

Group type: COMPARATOR
Intervention: Leaflet preservation
Number of subjects: 104
Study: 33491437

Group type: EXPERIMENTAL
Intervention: Maternal serum 25(OH)-vitamin D3 levels
Number of subjects: 539
Study: 33290437

Group type: EXPERIMENTAL
Intervention: Delayed-onset muscle soreness (DOMS) intervention (n = 20)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection (n = 20)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 50
Study: 35734655

Group type: EXPERIMENTAL
Intervention: Combined locomotor training and aerobic exercise (3 times/week, progressive increase in sets and repetitions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aerobic exercise (7 times/week for 30 min/session)
Number of subjects: 20
Study: 32162931

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 97
Study: 34280916

Group type: EXPERIMENTAL
Intervention: DP-SCIT for 1 year
Number of subjects: 307

Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 307
Study: 33317540

Group type: EXPERIMENTAL
Intervention: Marriage at/after age 18
Number of subjects: 1278

Group type: COMPARATOR
Intervention: Child-brides (married below age 18)
Number of subjects: 1278
Study: 34402980

Group type: EXPERIMENTAL
Intervention: Random-hatching (LR)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Negative control (NC)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sandblasting with Al2O3 (SB)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Crossed-lines (LC)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Parallel-waves (LW)
Number of subjects: 160
Study: 32943389

Group type: EXPERIMENTAL
Intervention: IVIG plus corticosteroids
Number of subjects: 210

Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 210
Study: 36286979

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg 1 time per day + Alfasoxx 1 sachet qid (intervention group)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg 1 time per day (control group)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Combination therapy (intervention group)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard PPI monotherapy (control group)
Number of subjects: 81
Study: 33170378

Group type: EXPERIMENTAL
Intervention: l-Carnosine (10–15 mg/kg in 2 divided doses) plus standard care (occupational and speech therapy)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard care (occupational and speech therapy)
Number of subjects: 67
Study: 33652243

Group type: EXPERIMENTAL
Intervention: Digestible lysine levels (0.714, 0.816, 0.918, 1.020, and 1.122%)
Number of subjects: 500
Study: 35078510

Group type: EXPERIMENTAL
Intervention: Intraoperative endoluminal pyloromyotomy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Atraumatic stretching of the pylorus
Number of subjects: 128
Study: 34062866

Group type: COMPARATOR
Intervention: Novel method using random forest for classification based on fusion features from gene sequence and subregions correlation.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hippocampal subregions and genes such as HATA, fimbria, parasubiculum, RYR3, and PRKCE.
Number of subjects: 0
Study: 36446797

Group type: EXPERIMENTAL
Intervention: Intensive assisted locomotion training (LOC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Neurorehabilitation protocol integrating assisted locomotion with a noninvasive brain-machine interface (L + BMI)
Number of subjects: 8

Group type: COMPARATOR
Intervention: L + BMI group
Number of subjects: 8
Study: 33353506

Group type: EXPERIMENTAL
Intervention: Manual massage
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Muscle energy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Rest control activity
Number of subjects: 17
Study: 35248015

Group type: EXPERIMENTAL
Intervention: CUIDA-TE APP (2-month EMI group, n≥58)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: MONITOR EMOCIONAL APP (2-month EMA only group, n≥58)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Wait-list control group (n≥58)
Number of subjects: 174